Skip to content
Riskpilot
← Back to search
Sign in
Get full access
HyperBio Therapeutics ApS
APS
In liquidation
Advertising protection
CVR 41244909
Stærmosevej 12, 7120
Vejle Øst
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2020 · 6 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
HyperBio Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (1)
SS
Søren Sylvester Skjærbæk
Management
Management
2020 – 2024
Board of directors
Non-executive oversight
Name
Role
Member since
Former (2)
MD
Morten Døssing
Chairman
Chairman
2020 – 2024
NB
Niccolo' Bacchi-Bønnelykke
Board of Directors
Board of Directors
2020 – 2021
Shareholders
As of last annual report
100%
Shareholder
Type
Ownership
Votes
Since
Novo Holdings A/S
Company
100%
100%
2020
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on HyperBio Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
